GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Cyclically Adjusted Price-to-FCF

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Cyclically Adjusted Price-to-FCF : (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Skystar Bio-Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, Skystar Bio-Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2014 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=0.457/98.9000*98.9000
=0.457

Current CPI (Sep. 2014) = 98.9000.

Skystar Bio-Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200412 0.628 74.488 0.834
200503 0.083 75.597 0.109
200506 -0.328 74.618 -0.435
200509 -0.430 75.290 -0.565
200512 -0.599 75.666 -0.783
200603 -0.078 76.340 -0.101
200606 -0.168 76.034 -0.219
200609 -0.081 76.413 -0.105
200612 0.121 77.793 0.154
200703 -0.154 78.884 -0.193
200706 -0.020 79.357 -0.025
200709 -0.487 81.276 -0.593
200712 0.549 82.911 0.655
200803 -0.187 85.485 -0.216
200806 -0.089 85.058 -0.103
200809 -0.060 85.057 -0.070
200812 0.812 83.956 0.957
200903 -0.038 84.457 -0.044
200906 -0.275 83.615 -0.325
200909 -0.468 84.369 -0.549
200912 0.127 85.386 0.147
201003 0.006 86.316 0.007
201006 -0.279 85.886 -0.321
201009 -0.387 87.267 -0.439
201012 1.003 89.289 1.111
201103 -0.695 91.154 -0.754
201106 -0.102 91.612 -0.110
201109 -0.222 92.711 -0.237
201112 0.107 92.885 0.114
201203 0.203 94.367 0.213
201206 -0.513 93.495 -0.543
201209 -0.443 94.482 -0.464
201212 1.302 95.237 1.352
201303 -0.993 96.372 -1.019
201306 -0.085 95.984 -0.088
201309 0.152 97.332 0.154
201312 0.350 97.624 0.355
201403 0.432 98.600 0.433
201406 0.521 98.200 0.525
201409 0.457 98.900 0.457

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Skystar Bio-Pharmaceutical Co  (FRA:GNJC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Skystar Bio-Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines